New combo therapy aims to shrink head and neck tumors before surgery
Disease control
Recruiting now
This phase II trial is testing whether combining low-dose radiotherapy with the immunotherapy drug Toripalimab before surgery can improve outcomes for people with advanced head and neck squamous cell carcinoma. About 22 participants will receive two cycles of the combination, the…
Phase: PHASE2 • Sponsor: Xiwei XU • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC